Addiction Treatment Practice Manage in 2026: What's Changed
The HHS OCR Breach Portal documented over 725 healthcare breaches in 2023. For practices dealing with addiction treatment practice management , the stakes are even higher — because downtime doesn’t just cost money, it delays patient care. That’s why Qventive approaches addiction treatment practice management differently than a generic IT company would.
Qventive has spent 30+ years building healthcare-exclusive IT expertise. Our Observe-Improve-Prevent methodology ensures every engagement starts with understanding your actual practice operations before recommending changes. Steve Gerbino founded this company in 1994 with a single focus: healthcare. That focus hasn’t changed.
Built for Addiction Treatment Workflows
Intake and assessment documentation, medication-assisted treatment (MAT) tracking, group therapy session logging, urine drug screen result integration, and discharge planning workflows.
Compliance context: 42 CFR Part 2 + HIPAA dual compliance for SUD records. EHR platforms we configure for addiction treatment: Kipu Health, Sunwave Health, BestNotes, Sigmund Software.
Evidence-Based Addiction Treatment Practice Manage Implementation
Three principles guide every addiction treatment practice manage engagement:
Depth over breadth. We serve one industry. That means our engineers spend their entire careers learning healthcare workflows, EHR platforms, and compliance frameworks — not splitting attention across retail, legal, and finance.
Evidence over assumptions. We observe your practice before configuring anything. Most implementations fail because someone assumed they understood the workflow. We don’t assume.
Prevention over repair. Any IT company can fix things after they break. We monitor 24/7 to catch issues before your team even notices them. That’s the difference between reactive support and proactive partnership.
Ready to Talk?
30-minute assessment. No pitch.
Resources
Why addiction treatment PM has specific compliance needs.
42 CFR Part 2 compliance
Federally-assisted SUD treatment programs operate under 42 CFR Part 2 — federal SUD records confidentiality regulation with specific protections beyond HIPAA baseline. Post-2024 alignment reduced some friction with HIPAA; core Part 2 distinctions remain (redisclosure restrictions, identity protection, consent structure). PM infrastructure must support Part 2-compliant record handling.
SAMHSA OTP licensing
Opioid treatment programs (methadone clinics) operate under 42 CFR Part 8 with SAMHSA licensing. Operational requirements — toxicology, counseling minimums, take-home dosing rules, physician oversight — drive PM workflow design. OTPs have specific workflow distinct from non-methadone SUD treatment.
DEA registration post-X-Waiver
X-Waiver was eliminated in 2023 — any DEA-registered practitioner can now prescribe buprenorphine for SUD (still requires specific DEA registration with Schedule III). Broader buprenorphine availability in primary care and psychiatric practice has changed SUD treatment landscape. SAMHSA MAT guidance.
Medication-assisted treatment operational patterns.
Buprenorphine (Suboxone, Zubsolv, Sublocade) — office-based treatment, sublingual or long-acting injectable. Workflow includes initial assessment, induction protocol (home-based vs office-based), maintenance dosing, toxicology monitoring, PDMP checking, and state-specific considerations.
Methadone — OTP-only, highly regulated. Daily observed dosing initially with graduated take-home privileges based on stability. OTP-specific workflow.
Naltrexone (Vivitrol) — long-acting injectable, monthly administration. Office administration workflow. Abstinence required before initiation (precipitated withdrawal risk); coordination with detox facilities for patients transitioning from opioids.
Specific billing workflow.
Group therapy billing — CPT 90853 for group psychotherapy, with specific documentation requirements including group census, session content, and individual participation. Group sizes and minutes requirements matter for billing integrity.
Toxicology billing — CMS drug testing coverage policy applies. Presumptive drug testing (CPT 80305-80307) for in-office rapid testing, definitive drug testing (G0480-G0483) for confirmatory testing when clinically indicated. Frequency limits apply; medical necessity documentation required.
MAT administration billing — Vivitrol injection (CPT 96372 administration + J2315 drug), Sublocade injection (CPT 96372 + J0572-J0575 depending on dose), oral buprenorphine is pharmacy benefit (not practice billing).
Counseling integration — individual counseling (CPT 90832-90838), family counseling (CPT 90846-90847), case management services. See our addiction treatment EHR IT page.
Your Addiction Treatment Practice Manage Questions, Answered
Ready to Modernize Your Practice Technology?
Schedule your free practice technology assessment. Our healthcare IT specialists will review your current systems, identify gaps, and outline a roadmap built specifically for your practice.
- 30 years of healthcare-only experience
- EHR-certified across 7 major platforms
- HIPAA-compliant from day one
- No long-term contracts required
